The ATHENA Trial - Will It Change Treatment Of Atrial Fibrillation
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivelsesdato: 2009
Originalsprog | Engelsk |
---|---|
Tidsskrift | Healthcare Bulletin |
Vol/bind | 1 |
Udgave nummer | 2 |
Status | Udgivet - 2009 |
Bibliografisk note
Atrial fibrillation is the most common arrhythmia encountered in clinical practice. In the ATHENA trial (A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention...Author: Ole Dyg Pedersen, MD, DMSC, Christian Torp-Pedersen, MD, DMSC
ID: 20684618